Cat.#: ACPP-1220
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1233 | Galectin 3 Blocking Peptide (AC1233) | 250 µg | inquiry |
| ACPP-1814 | PPA E.Coli (AC1814) | 5 µg | inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
| ACPP-1419 | Human TAC3 Protein (AC1419) | 5 µg | inquiry |
| ACPP-1105 | Human Leptin Protein (AC1105) | 200 µg | inquiry |
| ACPP-1804 | Human STMN2 Protein (AC1804) | 2 µg | inquiry |
| ACPP-1840 | Human ALDH1A1 Protein (AC1840) | 5 µg | inquiry |
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
| ACPP-1613 | Human RAB3IL1 Protein (AC1613) | 2 µg | inquiry |
| ACPP-1678 | Human SDCBP Protein (AC1678) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.